Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1993View

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

View Full Paper
Ask AI
Bookmark
Share

Authors

KAKaren H. AntmanJCJohn CrowleySBS P Balcerzak

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Antman et al. (1993) studied this question.

synapsesocial.com/papers/6a710d692163a0a01bc53baahttps://doi.org/10.1200/jco.1993.11.7.1276
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).1987 · 93 citations
  2. 2Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.1989 · 239 citations
  3. 3Protected environment–Prophylactic antibiotic program for malignant sarcomas: Randomized trial during remission induction chemotherapy1981 · 57 citations
  4. 4Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group Study1991 · 174 citations